Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-07-28

FDA Approved: GWYN LO — Original Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approval of GWYN LO, a combined oral contraceptive containing norelgestromin and ethinyl estradiol, from Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GWYN LO (NORELGESTROMIN AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for GWYN LO (NORELGESTROMIN AND ETHINYL ESTRADIOL)